Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis Pharmaceutical Investing
Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency Pharmaceutical Investing
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance Pharmaceutical Investing
AbbVie Announces Positive Topline Results from Phase 3 UP-AA Trial Evaluating Upadacitinib for Alopecia Areata Pharmaceutical Investing
AbbVie Submits for U.S. FDA Approval of Combination Treatment of VENCLEXTA® and Acalabrutinib for Previously Untreated Patients with Chronic Lymphocytic Leukemia Pharmaceutical Investing
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union Pharmaceutical Investing
BOTOX® Cosmetic Selects This Year's Entrepreneurs for The Confidence Project Pharmaceutical Investing
